CHINARES PHARMA (03320) has released the interim results for its subsidiary China Resources Jiangzhong Pharmaceutical Co.,Ltd. covering the six months ended June 30, 2026.
The unit posted total operating revenue of 1.932 billion yuan, reflecting a year-on-year decrease of 9.75%. Net profit attributable to shareholders of the listed company reached 491 million yuan, down 5.92% from the prior-year period.
Basic earnings per share stood at 0.78 yuan for the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.